Medihaler-Iso (Isoproterenol Sulfate Inhalation) - Summary

MEDIHALER-ISO SUMMARY

Medihaler-Iso™
(isoproterenol sulfate)
Inhalation Aerosol

MEDIHALER-ISO (isoproterenol sulfate) is a short-acting sympathomimetic administered by oral inhalation for the treatment of bronchoconstriction. Each metered dose of the aerosol delivers through the oral adapter 0.08 mg isoproterenol sulfate of appropriate particle size (the majority less than 5μ). This drug product also contains dichlorodifluoromethane, dichlorotetrafluoroethane, sorbitan trioleate, and trichloromonofluoromethane.

MEDIHALER-ISO is indicated for the treatment of reversible obstructive airways disease.

MEDIHALER-ISO NEWS HIGHLIGHTS

Clinical Trials Related to Medihaler-Iso (Isoproterenol Inhalation)

Vascular Response to Isoproterenol and β2 Adrenergic Receptor Polymorphisms [Completed]

Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas [Recruiting]

Isoproterenol Challenge to Detect Arrhythmogenic Right Ventricular Cardiomyopathy [Completed]

Pharmacological Modulation of the Intrarenal Pressure During Endourological Procedures in the Upper Urinary Tract [Completed]

Retrograde Intrarenal Stone Surgery - A Method of Treating the ESWL Resistant Kidney Stone [Active, not recruiting]

more>>